Thomas Arzberger

Active 1995–2025

104
Papers
20,646
Citations
73
h-index
103
i10-index

Citations

Citations per year for Thomas Arzberger1996: 1 citations1997: 1 citations1998: 3 citations1999: 6 citations2000: 6 citations2001: 15 citations2002: 8 citations2003: 11 citations2004: 15 citations2005: 14 citations2006: 36 citations2007: 38 citations2008: 103 citations2009: 104 citations2010: 105 citations2011: 112 citations2012: 82 citations2013: 189 citations2014: 196 citations2015: 259 citations2016: 304 citations2017: 356 citations2018: 287 citations2019: 994 citations2020: 1,098 citations2021: 1,137 citations2022: 937 citations2023: 752 citations2024: 1,170 citations2025: 573 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,047 citing papers, 25% of this breakdownUnited Kingdom: 1,189 citing papers, 9.8% of this breakdownGermany: 1,049 citing papers, 8.6% of this breakdownChina: 704 citing papers, 5.8% of this breakdownItaly: 631 citing papers, 5.2% of this breakdownCanada: 487 citing papers, 4% of this breakdownSpain: 475 citing papers, 3.9% of this breakdownNetherlands: 418 citing papers, 3.4% of this breakdownJapan: 371 citing papers, 3.1% of this breakdownFrance: 368 citing papers, 3% of this breakdownSweden: 363 citing papers, 3% of this breakdownAustralia: 346 citing papers, 2.8% of this breakdown
0%25%Other 22.4%

Fields

  • Medicine60.8%
  • Neuroscience19%
  • Biochemistry, Genetics and Molecular Biology16.2%
  • Immunology and Microbiology1.4%
  • Nursing0.8%
  • Environmental Science0.2%
  • Other1.6%

Topics

  • Alzheimer's disease research and treatments12.6%
  • Parkinson's Disease Mechanisms and Treatments7.3%
  • Amyotrophic Lateral Sclerosis Research5.8%
  • Neuroinflammation and Neurodegeneration Mechanisms5.4%
  • Dementia and Cognitive Impairment Research4.7%
  • Neurological disorders and treatments3.1%
  • Other61.1%

Coauthors

All papers

Open in search
  1. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

    Authors: , , , , - Acta Neuropathologica 2006 cited by 3,271

  2. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Kassubek, Florian Krismer, Johannes Levin, Stefan Lorenzl, Huw R. Morris, Peter J. Nestor, Wolfgang H. Oertel, Werner Poewe, Gil D. Rabinovici, James B. Rowe, Gerard D. Schellenberg, Klaus Seppi, Thilo van Eimeren, Gregor K. Wenning, Adam L. Boxer, Lawrence I. Golbe, Irene Litvan, for the Movement Disorder Society–endorsed PSP Study Group - Movement Disorders 2017 cited by 2,332

  3. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2018 cited by 592

  4. Distribution patterns of tau pathology in progressive supranuclear palsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2020 cited by 471

  5. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS

    Authors: , , , , , , , , , , , - Science 2013 cited by 1,297

  6. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giorgio Giaccone, Kimmo J. Hatanpaa, Richard Heale, Patrick R. Hof, Monika Hofer, Tibor Hortobágyi, K. A. Jellinger, Gregory A. Jicha, Paul G. Ince, Julia Kofler, Enikò Kövari, Jillian J. Kril, David Mann, Radoslav Matěj, Ann C. McKee, Catriona McLean, Ivan Milenković, Thomas J. Montine, Shigeo Murayama, Edward B. Lee, Jasmin Rahimi, Roberta Diehl Rodriguez, Annemieke J.M. Rozemüller, Julie A. Schneider, Christian Schultz, William W. Seeley, Danielle Seilhean, Colin Smith, Fabrizio Tagliavini, Masaki Takao, Dietmar Rudolf Thal, Jon B. Toledo, Markus Tolnay, Juan C. Troncoso, Harry V. Vinters, Serge Weis, Stephen B. Wharton, Charles L. White, Thomas Wısnıewskı, John Woulfe, Masahito Yamada, Dennis W. Dickson - Acta Neuropathologica 2015 cited by 530

  7. Tau deposition patterns are associated with functional connectivity in primary tauopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jost J. Rumpf, Matthias L. Schroeter, Joseph Claßen, Victor L. Villemagne, John Seibyl, Andrew Stephens, Edward B. Lee, David G. Coughlin, Armin Giese, Murray Grossman, Corey T. McMillan, Ellen Gelpí, Laura Molina‐Porcel, Yaroslau Compta, John C. van Swieten, Laura Donker Laat, Claire Troakes, Safa Al‐Sarraj, John Robinson, Sharon X. Xie, David J. Irwin, Sigrun Roeber, Jochen Herms, Mikael Simons, Peter Bartenstein, Virginia M. Lee, John Q. Trojanowski, Johannes Levin, Günter U. Höglinger, Michael Ewers - Nature Communications 2022 cited by 108

  8. ApoE attenuates unresolvable inflammation by complex formation with activated C1q

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 cited by 316

  9. Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain Pathology 2008 cited by 479

  10. Apolipoprotein E aggregation in microglia initiates Alzheimer’s disease pathology by seeding β-amyloidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2024 cited by 91

  11. MicroRNA‐125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease

    Authors: , , , , , , , - The EMBO Journal 2014 cited by 335

  12. The FTD‐like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism

    Authors: , , , , , , , , , , , , , , , , , , , - The EMBO Journal 2017 cited by 286

  13. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins

    Authors: , , , , , , , , , , , , , , - Acta Neuropathologica 2013 cited by 497

  14. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John C. van Swieten, Alex Rajput, Leslie W. Ferguson, Mark Cookson, J. Raphael Gibbs, Cornelis Blauwendraat, Jinhui Ding, Ruth Chia, Bryan J. Traynor, Alexander Pantelyat, Coralie Viollet, Bryan J. Traynor, Olga Pletniková, Juan C. Troncoso, Liana S. Rosenthal, Adam L. Boxer, Gesine Respondek, Thomas Arzberger, Sigrun Roeber, Armin Giese, David J. Burn, Nicola Pavese, Alexander Gerhard, Christopher Kobylecki, P. Nigel Leigh, Alistair Church, Michele T.M. Hu - The Lancet Neurology 2020 cited by 120

  15. Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion

    Authors: , , , , , , - Cell Death and Disease 2021 cited by 88

  16. The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

    Authors: , , , , , , , , , , , , , , , , , , - Movement Disorders 2014 cited by 379

  17. Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2009 cited by 329

  18. The Differential Diagnosis and Treatment of Atypical Parkinsonism

    Authors: , , , , - Deutsches Ärzteblatt international 2016 cited by 212

  19. In situ architecture of neuronal α-Synuclein inclusions

    Authors: , , , , , , , , , , - Nature Communications 2021 cited by 123

  20. Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

    Authors: , , , , , , , , , - Journal of Alzheimer s Disease 2007 cited by 321

  21. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex

    Authors: , , , , , , , , , , , , , , , , - Epigenetics & Chromatin 2018 cited by 256

  22. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Huw R. Morris, Jennifer L. Whitwell, Yaroslau Compta, Jean‐Christophe Corvol, Anthony E. Lang, James B. Rowe, Günter U. Höglinger, for the Movement Disorder Society‐endorsed PSP Study Group - Movement Disorders 2019 cited by 142

  23. Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naguib Mechawar, Andrea Schmitt, Brian Dean, Gustavo Turecki, Thomas M. Hyde, Elisabeth B. Binder - Acta Neuropathologica 2023 cited by 55

  24. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

    Authors: , , , , , , , , , , - Acta Neuropathologica 2013 cited by 343